The results are consistent and support the evidence that FMRP deficiency results in a severe deficit of OXPHOS efficiency during neurodevelopment, suggesting that dysfunctional mitochondria may contribute to the FXS phenotype. The gene discussed is FMR1; the disease is fragile X syndrome.